Daniel Yadegar M.D. Facc Rpvi

Daniel Yadegar, MD FACC RPVI, currently serves as Chief Medical Officer at Atria Institute since March 2024, while also holding positions as a Board Member and Investor at DermBiont, Inc. and as a Board Observer and Investor at iECURE, Inc. since October 2023 and February 2023 respectively. As Managing Partner at Double Point Ventures since January 2023, and as a Board Observer and Investor at Cleerly since July 2022, Daniel has demonstrated strong leadership in the medical and investment sectors. Furthermore, Daniel co-founded and serves as Chief Medical Officer for Wellbel since January 2019 and was Medical Director, Internist & Cardiologist at Holistic Integrative Health (HIH) until March 2024. Additionally, Daniel co-founded Newpath Partners, serving as Chief Medical Officer for Fund 1 until December 2023. Educational accomplishments include a Bachelor’s degree in Psychology (with Honors) from Harvard University and a Doctor of Medicine (M.D.) from Joan & Sanford I. Weill Medical College of Cornell University, earned between 2000 and 2004.